IPCA Laboratories Limited · NSE: IPCALAB · BSE: 524494
IPCA Laboratories
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 13 Aug 2026.
Q1 FY27 · Consolidated
Revenue
2,788.10₹ Cr
+20.8% vs year ago
Net profit
424.27₹ Cr
+82.2% vs year ago
EPS, basic
15.84₹
+72.4% vs year ago
Net margin
15.2%
+5.1 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 2,788.10 | +20.8% | 424.27 | +82.2% | 15.84 | 13 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 2,388.48 | +6.3% | 306.69 | +379.3% | 11.79 | 29 May 2026 |
| Q3 FY26Oct–Dec 2025 | 2,392.50 | +6.6% | 363.67 | +31.6% | 12.86 | 13 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 2,556.50 | +8.6% | 280.53 | +14.2% | 11.14 | 13 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 2,308.85 | +10.3% | 232.89 | +16.9% | 9.19 | 11 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 2,246.69 | +10.5% | 63.99 | 48x | 2.67 | 29 May 2025 |
| Q3 FY25Oct–Dec 2024 | 2,245.37 | +9.4% | 276.36 | +25.0% | 9.78 | 13 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 2,354.90 | +15.8% | 245.75 | +80.0% | 9.05 | 14 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 2,092.63 | +31.8% | 199.14 | +21.4% | 7.58 | 14 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 2,033.01 | +34.5% | 1.33 | −98.3% | 2.35 | 31 May 2024 |
| Q3 FY24Oct–Dec 2023 | 2,052.86 | +32.8% | 221.00 | +101.4% | 7.09 | 15 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 2,033.96 | +27.0% | 136.49 | −6.4% | 5.72 | 13 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 1,587.58 | +0.1% | 164.10 | +13.0% | 6.42 | 10 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 1,511.63 | +17.3% | 78.14 | −40.8% | 3.02 | 29 May 2023 |
| Q3 FY23Oct–Dec 2022 | 1,546.00 | +8.1% | 109.72 | −44.8% | 4.25 | 14 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 1,600.95 | +3.7% | 145.89 | −42.2% | 5.67 | 12 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 1,585.74 | +1.3% | 145.24 | −52.6% | 5.64 | 11 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 1,289.10 | +15.6% | 131.98 | −18.1% | 5.13 | 25 May 2022 |
| Q3 FY22Oct–Dec 2021 | 1,430.47 | +1.5% | 198.74 | −25.7% | 7.76 | 14 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 1,544.43 | +13.5% | 252.40 | −5.4% | 19.73 | 13 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 1,565.79 | +2.0% | 306.67 | −31.2% | 24.18 | 05 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 1,114.66 | +3.8% | 161.20 | +94.1% | 12.71 | 28 May 2021 |
| Q3 FY21Oct–Dec 2020 | 1,409.83 | +16.2% | 267.56 | +35.4% | 21.09 | 04 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 1,361.10 | +6.0% | 266.70 | +37.8% | 21.08 | 07 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 1,534.40 | +42.3% | 445.68 | +244.3% | 35.27 | 10 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 1,073.76 | — | 83.05 | — | 6.57 | 17 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 1,212.86 | — | 197.54 | — | 15.63 | 13 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 1,283.90 | — | 193.54 | — | 15.32 | 08 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 1,078.19 | — | 129.43 | — | 10.24 | 14 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 0.00 | — | 0.00 | — | 0.00 | 30 May 2019 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 2,119.24 | +21.3% | 373.29 | +42.5% | 14.71 | 13 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 1,814.35 | +10.7% | 262.29 | Turned profit | 10.34 | 29 May 2026 |
| Q3 FY26Oct–Dec 2025 | 1,845.18 | +11.0% | 303.45 | +13.4% | 11.96 | 13 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 1,930.32 | +6.6% | 304.74 | +24.8% | 12.01 | 13 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 1,746.90 | +11.6% | 262.04 | +28.4% | 10.33 | 11 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 1,638.44 | +8.5% | (65.05) | Turned loss | (2.56) | 29 May 2025 |
| Q3 FY25Oct–Dec 2024 | 1,662.68 | +10.3% | 267.56 | +95.4% | 10.55 | 13 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 1,810.94 | +8.9% | 244.12 | +50.6% | 9.62 | 14 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 1,565.86 | +5.2% | 204.13 | +22.5% | 8.05 | 14 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 1,510.62 | +7.8% | 64.76 | −23.7% | 2.55 | 31 May 2024 |
| Q3 FY24Oct–Dec 2023 | 1,506.83 | +5.2% | 136.94 | +13.9% | 5.40 | 15 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 1,662.67 | +12.0% | 162.13 | −3.4% | 6.39 | 13 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 1,488.71 | +1.3% | 166.58 | +15.8% | 6.57 | 10 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 1,401.63 | +20.0% | 84.82 | −23.2% | 3.34 | 29 May 2023 |
| Q3 FY23Oct–Dec 2022 | 1,432.79 | +7.9% | 120.27 | −44.9% | 4.74 | 14 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 1,484.88 | +4.3% | 167.78 | −34.9% | 6.61 | 12 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 1,469.28 | −0.6% | 143.82 | −49.5% | 5.67 | 11 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 1,168.45 | +12.3% | 110.41 | −27.1% | 4.35 | 25 May 2022 |
| Q3 FY22Oct–Dec 2021 | 1,328.47 | +1.0% | 218.17 | −16.1% | 8.60 | 14 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 1,423.84 | +9.7% | 257.64 | −6.5% | 20.31 | 13 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 1,478.60 | −0.4% | 284.72 | −37.2% | 22.45 | 05 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 1,040.92 | +3.6% | 151.48 | +18.6% | 11.94 | 28 May 2021 |
| Q3 FY21Oct–Dec 2020 | 1,315.22 | +15.5% | 259.97 | +32.2% | 20.49 | 04 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 1,297.77 | +7.0% | 275.68 | +40.6% | 21.79 | 07 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 1,485.25 | +46.9% | 453.64 | +243.5% | 35.90 | 10 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 1,004.79 | +20.5% | 127.76 | +16.7% | 10.11 | 17 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 1,139.07 | +20.2% | 196.63 | +22.8% | 15.56 | 13 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 1,212.56 | +21.5% | 196.02 | +63.7% | 15.51 | 08 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 1,011.01 | +18.4% | 132.05 | +101.5% | 10.45 | 14 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 833.81 | — | 109.47 | — | 8.67 | 30 May 2019 |
| Q3 FY19Oct–Dec 2018 | 947.59 | — | 160.18 | — | 12.68 | 12 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 997.82 | — | 119.74 | — | 9.48 | 14 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 853.93 | — | 65.52 | — | 5.19 | 10 Aug 2018 |
63 filings on record for this company.